Arcadia Biosciences (RKDA) Total Current Liabilities (2014 - 2025)

Arcadia Biosciences has reported Total Current Liabilities for 12 years, with the latest figure at $2.1 million in Q4 2025.

• For the quarter ending Q4 2025, Total Current Liabilities fell 19.66% year-over-year to $2.1 million; the trailing twelve-month figure through Dec 2025 stood at $2.1 million (down 19.66% YoY), and the FY2025 full-year result was $2.1 million, down 19.66% from the prior year.
• Total Current Liabilities for Q4 2025 stood at $2.1 million, down from $2.3 million in the prior quarter.
• The five-year high for Total Current Liabilities was $7.7 million in Q2 2021, with the low at $1.8 million in Q2 2025.
• Historically, Total Current Liabilities has averaged $3.9 million across 5 years, with a median of $4.0 million in 2022.
• Annual changes were most pronounced in 2024 — Total Current Liabilities tumbled 40.08% — and 2025, when it fell 1.85%.
• Arcadia Biosciences' Total Current Liabilities stood at $5.0 million in 2021, then dropped by 16.49% to $4.2 million in 2022, then declined by 14.71% to $3.6 million in 2023, then decreased by 28.61% to $2.6 million in 2024, then retreated by 19.66% to $2.1 million in 2025.
• The last three Total Current Liabilities figures came in at $2.1 million (Q4 2025), $2.3 million (Q3 2025), and $1.8 million (Q2 2025), per Business Quant data.